by Miami Stem Cell | Apr 6, 2020 | stem cell therapy
Hope Biosciences, a clinical stage biotechnology company focused on developing cell-based therapeutics for acute and chronic disease, today announced that FDA has approved a Phase II clinical trial evaluating efficacy and safety of Hope Biosciences’ autologous,...
by Miami Stem Cell | Apr 6, 2020 | stem cell therapy
Could stem cells help patients with the novel coronavirus disease COVID-19?It’s hard to say at this point. Is it worth doing trials during the outbreak to find out?Three new clinical studies have popped up on Clinicaltrials.gov investigating the potential of stem...
by Miami Stem Cell | Apr 6, 2020 | stem cell therapy
Researchers at Johns Hopkins University now have federal approval to test if blood plasma from recovered COVID-19 patients can help protect the heroes on the front line of the battle against the coronavirus. The hope is that transfusions of blood plasma would boost...
by Miami Stem Cell | Apr 6, 2020 | stem cell therapy
The Food and Drug Administration announced Friday it was taking the lead on a national effort to facilitate the use of plasma from recovered patients to treat patients infected with the coronavirus.The FDA program involves the Mayo Clinic and the American Red Cross,...
by Miami Stem Cell | Apr 6, 2020 | stem cell therapy
Could administration of convalescent plasma transfusion be beneficial in the treatment of critically ill patients with coronavirus disease 2019 (COVID-19)? In this uncontrolled case series of 5 critically ill patients with COVID-19 and acute respiratory distress...
